Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 59 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
ABAT
💬1. ABAT
| 7件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, Propanoate metabolism, Butanoate metabolism, Metabolic pathways, GABAergic synapse 7件: Alanine, aspartate and glutamate metabolism, Valine, leucine and isoleucine degradation, beta-Al ... | Valproic acid
Valproic acid
💬1. ABAT
| Valproic acid | 14件: 2 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256 💬1. ABAT
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
ADRB2
💬2. ADRB2
| 9件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation 9件: Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligan ... | Albuterol
Albuterol
💬2. ADRB2
| Salbutamol | 12件: 3 3, 11, 12, 13, 49, 85, 86, 89, 111, 113, 256, 299 💬2. ADRB2
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
ALDH5A1
💬3. ALDH5A1
| 3件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, Metabolic pathways | Valproic acid
Valproic acid
💬3. ALDH5A1
| Valproic acid | 14件: 2 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256 💬3. ALDH5A1
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
AR
💬4. AR
| 4件: Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer 4件: Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate canc ... | Testosterone
Testosterone
💬4. AR
| Testosterone | 8件: 1 1, 2, 3, 13, 60, 76, 78, 113 💬4. AR
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
CACNA1G
💬5. CACNA1G
| 8件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome 8件: MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis ... | Valproic acid
Valproic acid
💬5. CACNA1G
| Valproic acid | 14件: 2 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256 💬5. CACNA1G
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
CACNA1H
💬6. CACNA1H
| 7件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome 7件: MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis ... | Valproic acid
Valproic acid
💬6. CACNA1H
| Valproic acid | 14件: 2 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256 💬6. CACNA1H
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 |
CACNA1I
💬7. CACNA1I
| 7件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome 7件: MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis ... | Valproic acid
Valproic acid
💬7. CACNA1I
| Valproic acid | 14件: 2 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256 💬7. CACNA1I
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 |
GABRA1
💬8. GABRA1
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction 6件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse ... | Midazolam
Midazolam
💬8. GABRA1
| Midazolam | 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬8. GABRA1
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 |
GABRA2
💬9. GABRA2
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction 6件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse ... | Midazolam
Midazolam
💬9. GABRA2
| Midazolam | 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬9. GABRA2
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 |
GABRA3
💬10. GABRA3
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction 6件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse ... | Midazolam
Midazolam
💬10. GABRA3
| Midazolam | 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬10. GABRA3
|